The VSTM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VSTM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The VSTM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View VSTM Detailed Price Forecast - CNN Money||View VSTM Detailed Summary - Google Finance|
|View VSTM Detailed Summary - Yahoo! Finance||View VSTM Stock Research & Analysis - Zacks.com|
|View VSTM Trends & Analysis - Trade-Ideas||View VSTM Major Holders - Barrons|
|View VSTM Call Transcripts - NASDAQ||View VSTM Breaking News & Analysis - Seeking Alpha|
|View VSTM Annual Report - CompanySpotlight.com||View VSTM OTC Short Report - OTCShortReport.com|
|View VSTM Fundamentals - TradeKing||View VSTM SEC Filings - Bar Chart|
|View Historical Prices for VSTM - The WSJ||View Performance/Total Return for VSTM - Morningstar|
|View the Analyst Estimates for VSTM - MarketWatch||View the Earnings History for VSTM - CNBC|
|View the VSTM Earnings - StockMarketWatch||View VSTM Buy or Sell Recommendations - MacroAxis|
|View the VSTM Bullish Patterns - American Bulls||View VSTM Short Pain Metrics - ShortPainBot.com|
|View VSTM Stock Mentions - StockTwits||View VSTM Stock Mentions - PennyStockTweets|
|View VSTM Stock Mentions - Twitter||View VSTM Investment Forum News - Investor Hub|
|View VSTM Stock Mentions - Yahoo! Message Board||View VSTM Stock Mentions - Seeking Alpha|
|View Insider Transactions for VSTM - SECform4.com||View Insider Transactions for VSTM - Insider Cow|
|View VSTM Major Holdings Summary - CNBC||View Insider Disclosure for VSTM - OTC Markets|
|View Insider Transactions for VSTM - Yahoo! Finance||View Institutional Holdings for VSTM - NASDAQ|
|View VSTM Stock Insight & Charts - FinViz.com||View VSTM Investment Charts - StockCharts.com|
|View VSTM Stock Overview & Charts - BarChart||View VSTM User Generated Charts - Trading View|
Upcoming Catalysts Could Send This Unknown Stock Up 300% or More
Posted on Friday July 13, 2018
Dry Eye Syndrome is a huge market in the U.S., where Allergan's (AGN) Restasis has over $1.4 billion in sales annually. Investors haven't noticed, but a newly public Wize Pharma (WIZP) has an alternative drug that has been approved and used in parts of Europe for years. WIZP has U.S. rights to the drug and is running two clinical trials with results from the first to be released in the coming months.
Complimentary Technical Snapshots on Verastem and Three More Biotech Stocks
Posted on Friday July 06, 2018
Stock Research Monitor: RXII, SAGE, and SGMO LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want a free Stock Review on VSTM sign up now at www.wallstequities.com/registration . This morning, WallStEquities.com ...
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Thursday July 05, 2018
Verastem, Inc. (VSTM), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the grant of stock options to nine new employees to purchase an aggregate of 201,500 shares of Verastem Oncology’s common stock. The options were granted as an inducement material to the employees’ acceptance of employment with Verastem Oncology in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price equal to $6.95 per share, the closing price of Verastem Oncology's common stock as reported by Nasdaq on July 2, 2018.
Verastem Oncology to Participate in the Oppenheimer Boston Oncology Insight Summit
Posted on Monday July 02, 2018
Verastem, Inc. (VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the Company will participate in the Oppenheimer Boston Oncology Insight Summit on July 10-11, 2018, in Boston, Massachusetts. Members of Verastem Oncology’s executive team will participate in the event. Verastem, Inc. (VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients.